Square Pharmaceuticals Ltd.
SQURPHARMA · DSE · Pharmaceuticals
About the company
Square Pharmaceuticals is Bangladesh's largest pharmaceutical company by revenue and holds approximately 18% of the domestic pharmaceuticals market. It operates WHO-GMP-compliant manufacturing facilities and exports to over 45 countries, with an expanding oncology and biosimilar product portfolio. The company is part of the Square Group conglomerate.
| Exchange | DSE |
| Ticker | SQURPHARMA |
| Sector | Pharmaceuticals |
| Indicative market cap USD | $1.30B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (DSE), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Dhaka Stock Exchange — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Bangladesh
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.